Based on their analysis, the best portfolio to follow for BioTech investors/traders is Julian Baker's $10b portfolio.http://t.co/0qBmDGcdKk (@hedgemind)
$RIGL..$3.00..was granted Orphan drug designation by the FDA for their main Ph3 candidate. No company PR yet (mentioned by @biorunup) http://1.usa.gov/1PCSbbA
-I spoke to the company yesterday & their main IR contact is on vacation. I suspect that they will issue a PR next week. Could be good for the stock price.